Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome
Joint Authors
Bunker, Daniel
Kerr, Leslie Dubin
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-10-24
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Importance.
Rituximab was not effective in ameliorating the hearing loss in a patient with atypical Cogan’s syndrome.
Observations.
We report the case of a patient who developed acute bilateral uveitis and sensorineural hearing loss.
A diagnosis of atypical Cogan’s syndrome was made.
The patient’s hearing loss did not improve despite high dose steroids and azathioprine.
Rituximab was administered given a recent report of its efficacy in a patient with refractory disease; however, our patient’s hearing loss did not improve.
Conclusion.
Hearing loss in Cogan’s syndrome is difficult to treat.
Though rituximab was ineffective in our case, earlier administration in the disease course could be effective for future patients.
American Psychological Association (APA)
Bunker, Daniel& Kerr, Leslie Dubin. 2016. Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome. Case Reports in Rheumatology،Vol. 2016, no. 2016, pp.1-4.
https://search.emarefa.net/detail/BIM-1102671
Modern Language Association (MLA)
Bunker, Daniel& Kerr, Leslie Dubin. Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome. Case Reports in Rheumatology No. 2016 (2016), pp.1-4.
https://search.emarefa.net/detail/BIM-1102671
American Medical Association (AMA)
Bunker, Daniel& Kerr, Leslie Dubin. Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome. Case Reports in Rheumatology. 2016. Vol. 2016, no. 2016, pp.1-4.
https://search.emarefa.net/detail/BIM-1102671
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1102671